WHO ICTRP trial
Study to check Safety and Immune response of SII Inactivated Salk Polio Vaccine…
CTRI/2022/05/042363 · Clinical Trials Registry India (CTRI) · Recruiting
Key facts
| Trial ID | CTRI/2022/05/042363 |
|---|---|
| Public title | Study to check Safety and Immune response of SII Inactivated Salk Polio Vaccine (Adsorbed) in comparison with Sii Licensed Inactivated Poliovirus Vaccine (IPV) |
| Scientific title | A Phase II/III study, Multicenter, Double-Blind, Randomized, Active Controlled Study to evaluate Safety and Immunogenicity of SII Inactivated Salk Polio Vaccine (Adsorbed) in comparison with Sii Licensed Inactivated Poliovirus Vaccine (IPV) |
| Primary sponsor | Serum Institute of India Pvt Ltd |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase 2/ Phase 3 |
| Countries | India |
| Interventions | Intervention1: SII Inactivated Salk Polio Vaccine (Adsorbed): SII Inactivated Salk Polio Vaccine (Adsorbed), produced by Serum Institute of India Pvt. Ltd., is a sterile suspension of three types of inactivated poliovirus: Type 1 (Mahoney)… |
| Registration date | Apr 5, 2022 |
| Target size | 648 |
| Secondary IDs | IPV:01 Version: 2.0 dated 03 September 2021 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: